Surprisingly, the levels of these free radicals in cardiomyocytes treated with oltipraz were even higher than that treated with angiotensin II, a most important factor in the pathogenesis of hypertrophic cardiomyopathy [40], [41]. This evidence concerns the gene AGT and hypertrophic cardiomyopathy.